Your session is about to expire
← Back to Search
Collagenase
Treatment for Peyronie's Disease
N/A
Waitlist Available
Led By Ranjith Ramasamy, MD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 52 weeks
Awards & highlights
Summary
The purpose of this research study is to develop a database of patients with Peyronie's disease who are treated at the University of Miami. The collected data will help the researchers to better understand Peyronie's disease and its response to therapy.
Eligible Conditions
- Peyronie's Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 52 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~52 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Goniometer measurement to determine degree of curvature of PD.
Penile pain evaluation in Peyronie's Disease Questionnaire (PDQ).
Psychosexual changes in Peyronie's Disease Questionnaire (PDQ).
Secondary outcome measures
International Index of Erectile Function (IIEF) Scores
Find a Location
Who is running the clinical trial?
Endo PharmaceuticalsIndustry Sponsor
133 Previous Clinical Trials
33,081 Total Patients Enrolled
12 Trials studying Peyronie's Disease
1,865 Patients Enrolled for Peyronie's Disease
University of MiamiLead Sponsor
935 Previous Clinical Trials
422,137 Total Patients Enrolled
2 Trials studying Peyronie's Disease
102 Patients Enrolled for Peyronie's Disease
Ranjith Ramasamy, MDPrincipal Investigator - University of Miami
Univ of Miami Hosp & Clinics-Sylvester Comp Cancer Center, University of Miami Hospital
12 Previous Clinical Trials
704 Total Patients Enrolled
1 Trials studying Peyronie's Disease
80 Patients Enrolled for Peyronie's Disease
Share this study with friends
Copy Link
Messenger